Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
265740.KQ
SELLGet insider-trade alertsNFC Corporation · Consumer Defensive · South Korea · $60M · Avg Vol: $502K/d
27
StockRankQ
49
V
35
M
32
P/E (TTM)
8.0x
ROE
4.3%
D/E
0.2x
Dividend %
1.3%
COMPANY DESCRIPTION
NFC Corporation manufactures and sells cosmetic raw materials in South Korea, China, and internationally.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 20.5M | 27.9M | 26.2M | 46.7M | 31.5% |
| EPS | 0.07 | 0.13 | -0.10 | 0.37 | 75.0% |
| Shares | 17.9M | 17.9M | 17.9M | 17.9M | 0.0% |
| Debt | 7.9M | 9.3M | 9.0M | 10.1M | 8.2% |
| Equity | 37.3M | 39.6M | 36.0M | 42.6M | 4.5% |
| Op CF | 2.0M | -5.8M | 5.3M | 0.8M | -25.1% |
| Inv CF | -0.7M | -2.3M | 0.5M | -3.6M | — |
| Fin CF | 1.9M | 1.2M | -0.5M | 0.9M | — |
Loading...
PRICE (1Y)-31.4%
SMA 50SMA 200
Close
$2.95
RSI (14)
42.2
52W High
$6.42
From 52W High
0.5%
SCORE BREAKDOWN
Quality
49
ROIC
18.6%82.6
ROE
4.3%26.4
GP/Assets
8.3%8.2
Op. Margin
9.4%59.3
FCF/Assets
0.3%18.1
Piotroski
769.0
Int. Cover
28.5x64.7
D/E Ratio
0.16x71.4
Current Ratio
1.85x60.5
Value
35
P/E (TTM)
8.0x90.2
EV/EBITDA
20.1x14.6
P/FCF
365.7x2.5
P/B
1.2x62.0
P/S
2.4x19.7
Div Yield
1.3%15.5
Momentum
32
52W High %
46%9.2
RS 6M
-105%7.3
SMA 50/200
1.01x61.6
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
99%87.6
FUNDAMENTALS
Market Cap
$60M
P/E (Forward)
—
Gross Margin
22.6%
SECTOR PEERS
Closest peers in Consumer Defensive, ranked by industry match, size, and score similarity. Cross-listings of 265740.KQ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 265740.KQ | NFC Corporation(you) | $60M | 27 | SELL |
| 214420.KS | Tonymoly Co., Ltd | $71M | 29 | SELL |
| 003350.KS | Hankook Cosmetics Manufacturing Co., Ltd | $86M | 24 | SELL |
| 012690.KS | Monalisa Co., Ltd | $60M | 9 | STRONG SELL |
| 123690.KS | Hankook Cosmetics Co., Ltd. | $62M | 8 | STRONG SELL |
| 024720.KS | Kolmar Holdings Co.,Ltd. | $164M | 28 | SELL |
| 352480.KQ | C&C International Co., Ltd. | $177M | 22 | SELL |
| 025620.KS | Cha AI Healthcare Co., Ltd. | $68M | 0 | STRONG SELL |
| 256940.KQ | Keeps Biopharma Inc. | $72M | 0 | STRONG SELL |
| 123330.KQ | Genic Co., Ltd. | $117M | 50 | HOLD |
Peer medians: ROE 5.5% · P/E 10.7x · Gross margin 26.4%